Repurposing of Chlorpromazine in Covid-19 Treatment (reCoVery)

Clinical Trial ID NCT04366739

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04366739

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020 7.78
2 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
3 Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993 5.62
4 Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006 3.33
5 Parenteral treatment of episodic tension-type headache: a systematic review. Headache 2014 2.06
6 Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog 2014 1.69
7 Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 2014 1.66
8 Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 2011 1.37
9 Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 2014 1.34
10 The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache 2015 1.15
11 Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15. J Virol 2008 0.89
12 Treatment of chronic hiccups in cancer patients: a systematic review. J Palliat Med 2012 0.84
13 Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic 2015 0.79
14 Fluorescence dequenching assays of coronavirus fusion. Adv Exp Med Biol 2006 0.78
Next 100